Skip to main content
WeightCited

Omega-3 관련 대사증후군

B 근거 적어도 하나의 무작위 시험이 이를 지지하며, 대체로 일관된 결과를 보입니다.

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'weightcited.com'; const params = 'ingredient\u003Domega\u002D3\u0026condition\u003Dmetabolic\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

결론

Systematic review of 44 RCTs found omega-3 significantly reduces triglycerides by 15-30% and reduces waist circumference by 0.81 cm. Fish oil combined with exercise produces greater body fat reduction than either alone. Benefits include PPAR-gamma activation and anti-inflammatory effects.

Key Study Findings

Randomized Controlled Trial 12 weeks Open-label
Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized …
Dose: Mediterranean diet vs: Standard diet Outcome: HDL/LDL subfractions and metabolic syndrome 효과: None None

대상 집단: Patients with psoriatic arthritis

Review
A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation.
Dose: None vs: None Outcome: Chronic inflammation linking stress, depression, IR 효과: None None

대상 집단: Review of metabolic syndrome and depression

Randomized Controlled Trial n=45 16 weeks
Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids.
Dose: 4 g/day P-OM3 vs: Healthy controls + MetSyn placebo Outcome: Lipoprotein oxylipin profiles 효과: None None

대상 집단: MetSyn patients vs healthy controls

Review
Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome.
Dose: None vs: None Outcome: None 효과: None None

대상 집단: None

Key Statistics

44

연구

3000

참여자

Positive

B

등급

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

일반적으로 사용되는 용량

general:
250-500 mg EPA+DHA/day
antiinflammatory:
2,000-4,000 mg/day
weightmanagement:
1,000-3,000 mg EPA+DHA/day

상한량: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

연구에서 사용된 용량

용량 기간 효과 N
Mediterranean diet 12 weeks Positive --
None -- Neutral --
4 g/day P-OM3 16 weeks Positive 45
None -- Positive --

권장 복용 시간: With meals containing fat for absorption; may split dose AM/PM

Safety & Side Effects

보고된 부작용

  • Fishy aftertaste
  • GI discomfort
  • Increased bleeding time (at high doses)
  • Nausea

알려진 상호작용

  • Blood thinners (may enhance anticoagulant effect at high doses)
  • Blood pressure medications (additive effect)
  • Orlistat (reduced absorption)

일일 최대 섭취 허용량: 5,000 mg EPA+DHA/day (FDA GRAS); may increase bleeding time at high doses

건강기능식품을 복용하기 전에 반드시 의료 전문가와 상담하십시오.

Frequently Asked Questions

Does Omega-3 help with 대사증후군?
Based on 44 studies with 3,000 participants, there is moderate evidence from clinical studies that Omega-3 may support 대사증후군 management. Our evidence grade is B (Good Evidence).
How much Omega-3 should I take for 대사증후군?
Studies have used various dosages. A commonly studied range is 250-500 mg EPA+DHA/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Omega-3?
Reported side effects may include Fishy aftertaste, GI discomfort, Increased bleeding time (at high doses), Nausea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Omega-3 and 대사증후군?
We rate the evidence as Grade B (Good Evidence). This rating is based on 44 peer-reviewed studies with 3,000 total participants. The overall direction of effect is positive.

관련 다른 성분: 대사증후군

Omega-3 다른 건강 상태에 대한 근거

References

  1. [1] Daniele Scherer et al.. Adv Rheumatol. 2024. Nutritional effect on lipoproteins and their subfractions in patients with Psoriatic Arthritis: a 12-week randomized trial-the DIETA trial. doi:10.1186/s42358-024-00389-5 PubMed
  2. [2] Seema Mehdi et al.. Biochem Biophys Rep. 2023. A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. doi:10.1016/j.bbrep.2023.101571 PubMed
  3. [3] Jannis Kountouras et al.. Clin Nutr. 2022. Comments on "dose-related meta-analysis for omega-3 fatty acids supplementation on major adverse cardiovascular events". doi:10.1016/j.clnu.2022.06.015 PubMed
  4. [4] Gregory C Shearer et al.. Prostaglandins Leukot Essent Fatty Acids. 2018. Abnormal lipoprotein oxylipins in metabolic syndrome and partial correction by omega-3 fatty acids. doi:10.1016/j.plefa.2017.10.006 PubMed
  5. [5] Leyre Martínez-Fernández et al.. Prostaglandins Other Lipid Mediat. 2015. Omega-3 fatty acids and adipose tissue function in obesity and metabolic syndrome. doi:10.1016/j.prostaglandins.2015.07.003 PubMed

FDA 면책 조항: 이 내용은 미국 식품의약국(FDA)의 평가를 받지 않았습니다. 이 웹사이트의 제품 및 정보는 질병의 진단, 치료, 완치 또는 예방을 목적으로 하지 않습니다. 제시된 근거 등급은 발표된 동료 심사 연구에 대한 우리의 분석에 기반하며, 의학적 조언을 구성하지 않습니다. 건강기능식품 복용을 시작하기 전에 반드시 의료 전문가와 상담하십시오.